Three-day global meet on diabetes to commence at Kovalam on Friday

Trivandrum / July 9, 2026

Thiruvananthapuram, July 09: The 14th edition of the Annual Global Diabetes Convention will get underway at Kovalam on Friday (July 10), bringing together leading diabetes specialists, physicians, researchers, nutritionists, diabetes educators and healthcare professionals.

"Helping You Choose the Best in Care" is the focal theme of the three-day convention, organised by Jothydev's Professional Education Forum (JPEF).

The event is packed with deliberations onlive topics including latest evidence-based treatment approaches, emerging technologies and practical clinical strategies aimed at improving diabetes prevention, diagnosis and management.

Health Minister Shri K Muraleedharan will deliver the inaugural address at the convention on July 11 at 4 pm at Uday Samudra, Kovalam. The plenary sessions and deliberations will get underway on July 10. The minister will release the IJDT (International Journal of Diabetes and Technology)-JPEF Abstracts 2026 during the inaugural ceremony.

Recognised as one of India's leading academic forums dedicated to diabetes care, JPEF has been designed to help clinicians navigate the rapidly evolving treatment landscape by combining scientific evidence with real-world clinical practice.

The convention assumes added significance since diabetes continues to pose one of India's biggest public health challenges, making continued medical education increasingly important.

The conference is being organised under the leadership of Dr Jothydev Kesavadev, organising Secretary of JPEF and Chairman and Managing Director of Jothydev's Diabetes Research Centre, along with Dr Arun Shankar, Organising Chairman, Sunitha Jothydev, Conference Director, Hariprasad, Convener, and Anjana Basanth, Scientific Coordinator.

The scientific programme has been developed with guidance from a multidisciplinary committee comprising leading diabetes specialists from across India and internationally.

The event will see 2,500 healthcare professionals sharing their experience, insights and perspectives for three days of cutting-edge scientific learning across three parallel halls.

The convention will feature an eminent faculty comprising internationally renowned diabetologists and researchers from Singapore, Austria, Nepal, Malaysia, Oman, the UAE, and Egypt, alongside more than 70 distinguished national experts from leading healthcare institutions in India.

Among the key highlights of the event will be sessions on next-generation obesity therapies, new medications such as Baxdrostat and Vicadrostat, advances in Continuous Glucose Monitoring (CGM), AI-driven personalised diabetes care, automated insulin delivery systems, stem cell research, Teplizumab for Type 1 diabetes, once-weekly basal insulin, inhaled insulin, geriatric diabetes management, and body composition analysis for precision metabolic care.

Ends